MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the completion and delivery of its first prototype Edge AI Intoxication Detection Kiosks, a hardware and software platform designed to detect intoxication and fatigue through AI-powered voice analysis. The kiosks are intended for workplace environments and are being developed to help improve safety across industries where drug, alcohol and fatigue monitoring are critical.
The company said the prototypes will now undergo testing, model validation and data analysis in collaboration with industry participants, speech experts and software engineers. MindBio is targeting sectors including mining, aviation, construction, heavy transport and law enforcement, where regulatory requirements and high-volume testing needs create demand for scalable, noninvasive intoxication and fatigue detection solutions.
The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The Company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
This development marks a significant step forward in workplace safety technology. Traditional methods of intoxication detection, such as breathalyzers and blood tests, are often invasive, time-consuming, and require trained personnel. In contrast, MindBio's voice-based system offers a noninvasive and scalable alternative that could be deployed in high-volume settings, potentially reducing accidents and improving compliance with safety regulations.
The implications of this technology extend beyond immediate safety benefits. For industries like mining and construction, where fatigue and impairment are leading causes of incidents, a rapid, noninvasive detection tool could revolutionize monitoring protocols. Similarly, in aviation and heavy transport, where even slight impairment can have catastrophic consequences, such a system could provide an additional layer of security.
MindBio's focus on Edge AI—processing data locally on the device rather than in the cloud—also addresses privacy and latency concerns. By analyzing voice samples on the kiosk itself, the system can deliver real-time results without transmitting sensitive data over networks, which is crucial for compliance with data protection regulations.
As the prototypes enter testing, the company will be working with industry partners to validate the model's accuracy and refine the user experience. If successful, MindBio could capture a significant share of the market for workplace intoxication detection, which is increasingly seeking noninvasive and efficient solutions. The company's newsroom at https://ibn.fm/MBQIF provides further updates on the progress of this technology.
For more information on MindBio Therapeutics, the full press release is available at https://ibn.fm/wySa8.
